Research progress on the targeting of glutamate racemase of Streptococcus mutans

doi:10.3877/cma.j.issn.1674-1366.2016.05.010

Abstract

Abstract:

Streptococcus mutans (S.mutans) is widely considered to be the major etiological factor responsible for dental caries in humans. Strategies selectively inhibiting the specific virulence factors associated with its cariogenicity are promising. Glutamate racemase (MurI) is a cofactor-independent enzyme that catalyzes the interconversion of L-glutamate to D-glutamate, one of the essential amino acids present in the peptidoglycan. As the indispensable enzyme in peptidoglycan biosynthesis, MurI has therefore been an attractive target for therapeutic interventions. In this review, the classifications, structures, inhibitors and genetic studies of MurI are systematically summarized. A comprehensive understanding of the relationship between MurI and cariogenic virulence of S.mutans can provide an important theoretical basis for potential therapeutic applications of dental caries.

Key words: Glutamate racemase, Inhibitor, Gene deletion mutation, Cariogenic virulence

Jianying Zhang, Junqi Ling. Research progress on the targeting of glutamate racemase of Streptococcus mutans[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2016, 10(05): 352-355.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhkqyxyjzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1366.2016.05.010

https://zhkqyxyjzz.cma-cmc.com.cn/EN/Y2016/V10/I05/352

References 30

[1]	Banas JA. Virulence properties of Streptococcus mutans[J]. Front Biosci，2004(9):1267-1277.
[2]	凌均棨.变形链球菌感受态形成的基因调控网络[J].中华口腔医学杂志，2015，50(6):342-345.
[3]	Bugg TD, Braddick D, Dowson CG，et al. Bacterial cell wall assembly：still an attractive antibacterial target[J]. Trends Biotechnol，2011，29(4):167-173.
[4]	Barreteau H, Kovac A, Boniface A，et al. Cytoplasmic steps of peptidoglycan biosynthesis[J]. FEMS Microbiol Rev，2008，32(2):168-207.
[5]	Cava F, Lam H, de Pedro MA，et al. Emerging knowledge of regulatory rols of D-amino acids in bacteria[J]. Cell Mol Life Sci，2011，68(5):817-813.
[6]	Ayengar P, Roberts E. Utilization of D-glutamic acid by Lactobacillus arabinosus：glutamic racemase[J]. J Biol Chem，1952，197(1):453-460.
[7]	Balikó G, Venetianer P. An Escherichia coli gene in search of a function：phenotypic effects of the gene recently identified as murI[J]. J Bacteriol，1993，175(20):6571-6577.
[8]	Lundqvist T, Fisher SL, Kern G，et al. Exploitation of structural and regulatory diversity in glutamate racemases[J]. Nature，2007，447(7146):817-822.
[9]	Kim KH, Bong YJ, Park JK，et al. Structural basis for glutamate racemase inhibition[J]. J Mol Biol，2007，372(2):434-443.
[10]	Kim WC, Rhee HI, Park BK，et al. Isolation of peptide ligands that inhibit glutamate racemase activity from a random phage display library[J]. J Biomol Screen，2000，5(6):435-440.
[11]	Kimura K, Tran LS, Itoh Y. Roles and regulation of the glutamate racemase isogenes，racE and yrpC，in Bacillus subtilis[J]. Microbiology，2004，150(Pt 9):2911-2920.
[12]	Sengupta S, Nagaraja V. Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI[J]. FEMS Microbiol Lett，2008，279(1):40-47.
[13]	Fisher SL. Glutamate racemase as a target for drug discovery[J]. Microbial Biotechnology，2008，1(5):345-360.
[14]	Pucci MJ, Thanassi JA, Ho HT，et al. Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities，a glutamate racemase and a D-amino acid transaminase[J]. J Bacteriol，1995，177(2):336-342.
[15]	de Jonge BL, Kutschke A, Newman JV，et al. Pyridodiazepine amines are selective therapeutic agents for Helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy[J]. Antimicrob Agents Chemother，2015，59(4):2337-2342.
[16]	Gallo KA, Knowles J. Purification，cloning，and cofactor independence of glutamate racemase from Lactobacillus[J]. Biochemistry，1993，32(15):3981-3990.
[17]	Nakajima N, Tanizawa K, Tanaka H，et al. Cloning and expression in Escherichia coli of the glutamate racemase gene from Pediococcus pentosaceus[J]. Agric Biol Chem，1986，50(11):2823-2830.
[18]	Bhagavan NV. Medical biochemistry. Chapter 6：Enzymes I：General Properties，Kinetics，and Inhibition[M]. 4th ed. Academic Press，2001：85-108.
[19]	Ashiuchi M, Yoshimura T, Esaki N，et al. Inactivation of glutamate racemase of Pediococcus pentosaceus with L-serine-O-sulfate[J]. Biosci Biotech Biochem，1993，57(11):1978-1979.
[20]	Glavas S, Tanner ME. The inhibition of glutamate racemase by D-N-hydroxylglutamate[J]. Bioorg Med Chem Let，1997，7(17):2265-2270.
[21]	Tanner ME, Miao S. The synthesis and stability of aziridino-glutamate，an irreversible inhibitor of glutamate racemase[J]. Tet Let，1994，35(24):4073-4076.
[22]	de Jonge BL, Kutschke A, Uria-Nickelsen M，et al. Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase（MurI）[J]. Antimicrob Agents Chemother，2009，53(8):3331-3336.
[23]	Choi SY, Esaki N, Ashiuchi M，et al. Bacterial glutamate racemase has high sequence similarity with myoglobins and forms an equimolar inactive complex with hemin[J]. Proc Natl Acad Sci USA，1994，91(21):10144-10147.
[24]	Corrigan RM, Abbott JC, Burhenne H，et al. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress[J]. PLoS Pathog，2011，7(9):e1002217.
[25]	Doublet P, van Heijenoort J, Bohin JP，et al. The murI gene of Escherichia coli is an essential gene that encodes a glutamate racemase activity[J]. J Bacteriol，1993，175(10):2970-2979.
[26]	Morayya S, Awasthy D, Yadav R，et al. Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis[J]. Gene，2015，555(2):269-276.
[27]	Li Y, Mortuza R, Milligan DL，et al. Investigation of the essentiality of glutamate racemase in Mycobacterium smegmatis[J]. J Bacteriol，2014，196(24):4239-4244.
[28]	Oh SY, Richter SG, Missiakas DM，et al. Glutamate racemase mutants of Bacillus anthracis[J]. J Bacteriol，2015，197(11):1854-1861.
[29]	Zhang J, Liu J, Ling J，et al. Inactivation of glutamate racemase（MurI）eliminates virulence in Streptococcus mutans[J]. Microbiol Res，2016(186-187):1-8.
[30]	樊明文.牙体牙髓病学[M]. 4版.北京：人民卫生出版社，2012：18.

Please choose a citation manager

Content to export